Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2006-11-10
2009-12-22
Shameem, Golam M (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C546S112000, C546S152000, C546S268100, C546S272700, C546S274100, C544S242000, C544S245000, C544S253000, C544S283000, C514S256000, C514S258100, C514S299000
Reexamination Certificate
active
07635702
ABSTRACT:
Novel imidazole compounds, including derivatives thereof, to intermediates for their preparation, to pharmaceutical compositions containing them and to their medicinal use are described. The compounds of the present invention are potent inhibitors of transforming growth factor (“TGF”)-signaling pathway. They are useful in the treatment of various TGF-related disease states including, for example, cancer and fibrotic diseases.
REFERENCES:
patent: 3707475 (1972-12-01), Lombardino
patent: 5656644 (1997-08-01), Adams et al.
patent: 6958354 (2005-10-01), Munchhof et al.
patent: 7030125 (2006-04-01), Munchhof et al.
patent: 7053095 (2006-05-01), Munchhof et al.
patent: 7153872 (2006-12-01), Munchhof et al.
patent: 2004/0106608 (2004-06-01), Munchhof et al.
patent: 2004/0110797 (2004-06-01), Munchhof et al.
patent: 2004/0176390 (2004-09-01), Blumberg et al.
patent: 0257897 (1988-03-01), None
patent: WO 98/52937 (1998-11-01), None
patent: WO 98/52941 (1998-11-01), None
patent: WO 00/31063 (2000-06-01), None
patent: WO 00/61576 (2000-10-01), None
patent: 01/62756 (2001-08-01), None
patent: WO 01/62756 (2001-08-01), None
patent: WO 01/72737 (2001-10-01), None
patent: WO 02/16359 (2002-02-01), None
patent: WO 02/40468 (2002-05-01), None
patent: WO 02/40476 (2002-05-01), None
patent: WO 02/055077 (2002-07-01), None
patent: WO 02/062787 (2002-08-01), None
patent: WO 02/062794 (2002-08-01), None
patent: WO 02/066462 (2002-08-01), None
patent: WO 02/072576 (2002-09-01), None
patent: WO 03/087304 (2003-10-01), None
patent: WO 2004/013135 (2004-02-01), None
Gaster et al (2001): STN International HCAPLUS database, (Columbus, Ohio), Accession No. 2001:636071.
Lombardino, Joseph George (1972): STN International HCAPLUS database, (Columbus, Ohio), Accession No. 1972:501607.
Yagi et al., “Freezing of equilibrium of imidazoles by inclusion crystallization with a host compound: isolation of the different tautomeric types in a pure state”, CrystEngComm, 4(25):143-145, 2002.
Singh et al., “Successful Shape-Based Virtual Screening: The Discovery of a Potent Inhibitor of the Type I TGFbeta Receptor Kinase (TbetaRI)”, Bioorganic & Medicinal Chemistry Letters, vol. 13, No. 24, 2003, pp. 4355-4359.
PCT International Search Report from PCT/IB03/03833, mailed Dec. 9, 2003.
Blumberg Laura C.
Munchhof Michael J.
Englemann John H.
Goodman Rosanne
Pfizer Inc.
Pfizer Products Inc.
Shameem Golam M
LandOfFree
Imidazole compounds as transforming growth factor (TGF)... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Imidazole compounds as transforming growth factor (TGF)..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Imidazole compounds as transforming growth factor (TGF)... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4137474